PLoS Genetics, ISSN 1553-7390, 09/2018, Volume 14, Issue 9, p. e1007693
GATA transcription factors play a crucial role in the regulation of immune functions across metazoans. In Caenorhabditis elegans, the GATA transcription factor...
RNA-POLYMERASE-II | VISUALIZATION | ATPASE SUG1 | RECRUITMENT | PROTEIN INTERACTIONS | CAENORHABDITIS-ELEGANS | PSEUDOMONAS-AERUGINOSA INFECTION | GENETICS & HEREDITY | FACTOR ELT-2 | C-ELEGANS | 26S PROTEASOME | Pseudomonas aeruginosa - immunology | Proteasome Inhibitors - pharmacology | Animals, Genetically Modified | Gene Expression Regulation - immunology | Immunity, Innate - genetics | Caenorhabditis elegans Proteins - metabolism | ATPases Associated with Diverse Cellular Activities - genetics | GATA Transcription Factors - genetics | Protein Binding - immunology | Gene Knockdown Techniques | Host-Pathogen Interactions - immunology | Caenorhabditis elegans - physiology | Animals | GATA Transcription Factors - metabolism | Host-Pathogen Interactions - genetics | Pseudomonas aeruginosa - pathogenicity | RNA Interference | ATPases Associated with Diverse Cellular Activities - metabolism | Transcription, Genetic - immunology | Proteasome Endopeptidase Complex - metabolism | Caenorhabditis elegans Proteins - genetics | Caenorhabditis elegans | Transcription factors | Bacterial infections | Analysis | Research | Genetic regulation | Ubiquitin-proteasome system | Infection control
RNA-POLYMERASE-II | VISUALIZATION | ATPASE SUG1 | RECRUITMENT | PROTEIN INTERACTIONS | CAENORHABDITIS-ELEGANS | PSEUDOMONAS-AERUGINOSA INFECTION | GENETICS & HEREDITY | FACTOR ELT-2 | C-ELEGANS | 26S PROTEASOME | Pseudomonas aeruginosa - immunology | Proteasome Inhibitors - pharmacology | Animals, Genetically Modified | Gene Expression Regulation - immunology | Immunity, Innate - genetics | Caenorhabditis elegans Proteins - metabolism | ATPases Associated with Diverse Cellular Activities - genetics | GATA Transcription Factors - genetics | Protein Binding - immunology | Gene Knockdown Techniques | Host-Pathogen Interactions - immunology | Caenorhabditis elegans - physiology | Animals | GATA Transcription Factors - metabolism | Host-Pathogen Interactions - genetics | Pseudomonas aeruginosa - pathogenicity | RNA Interference | ATPases Associated with Diverse Cellular Activities - metabolism | Transcription, Genetic - immunology | Proteasome Endopeptidase Complex - metabolism | Caenorhabditis elegans Proteins - genetics | Caenorhabditis elegans | Transcription factors | Bacterial infections | Analysis | Research | Genetic regulation | Ubiquitin-proteasome system | Infection control
Journal Article
Frontiers in Microbiology, ISSN 1664-302X, 2014, Volume 5, Issue 643, p. 643
Polymyxins are polycationic antimicrobial peptides that are currently the last-resort antibiotics for the treatment of multidrug-resistant, Gram-negative...
Antibiotic resistance | Mutation | Non-fermentative bacilli | Two-component systems | Lipid A | Enterobacteriaceae | Lipopolysaccharides | IN-VIVO EMERGENCE | 2-COMPONENT REGULATORY SYSTEM | lipopolysaccharides | lipid A | UDP-GLUCOSE DEHYDROGENASE | COLISTIN-RESISTANCE | MICROBIOLOGY | non-fermentative bacilli | AMINO-ACID SUBSTITUTION | MEMBRANE PROTEIN OPRH | mutation | ACINETOBACTER-BAUMANNII | antibiotic resistance | PSEUDOMONAS-AERUGINOSA | CATIONIC ANTIMICROBIAL PEPTIDES | two-component systems | KLEBSIELLA-PNEUMONIAE | Life Sciences | Microbiology and Parasitology | Bacteriology
Antibiotic resistance | Mutation | Non-fermentative bacilli | Two-component systems | Lipid A | Enterobacteriaceae | Lipopolysaccharides | IN-VIVO EMERGENCE | 2-COMPONENT REGULATORY SYSTEM | lipopolysaccharides | lipid A | UDP-GLUCOSE DEHYDROGENASE | COLISTIN-RESISTANCE | MICROBIOLOGY | non-fermentative bacilli | AMINO-ACID SUBSTITUTION | MEMBRANE PROTEIN OPRH | mutation | ACINETOBACTER-BAUMANNII | antibiotic resistance | PSEUDOMONAS-AERUGINOSA | CATIONIC ANTIMICROBIAL PEPTIDES | two-component systems | KLEBSIELLA-PNEUMONIAE | Life Sciences | Microbiology and Parasitology | Bacteriology
Journal Article
Virulence, ISSN 2150-5594, 04/2017, Volume 8, Issue 3, pp. 261 - 274
Infectious diseases caused by bacterial pathogens reduce the fitness of their associated host but are generally limited in duration. In order for the diseased...
acute | infectious | C. elegans | ELT-2 | infection | disease | GATA | innate | immunity | recovery | resolution | p38 MAPK | host | pathogen | PMK-1 | P. aeruginosa | INNATE IMMUNE-RESPONSE | aeruginosa | MICROBIOLOGY | LIPID MEDIATORS | INTESTINE | IMMUNOLOGY | PATHOGENESIS | CAENORHABDITIS-ELEGANS | GENES | SALMONELLA-TYPHIMURIUM | elegans | INFECTIOUS DISEASES | TRANSLATIONAL INHIBITION | VIRULENCE FACTORS
acute | infectious | C. elegans | ELT-2 | infection | disease | GATA | innate | immunity | recovery | resolution | p38 MAPK | host | pathogen | PMK-1 | P. aeruginosa | INNATE IMMUNE-RESPONSE | aeruginosa | MICROBIOLOGY | LIPID MEDIATORS | INTESTINE | IMMUNOLOGY | PATHOGENESIS | CAENORHABDITIS-ELEGANS | GENES | SALMONELLA-TYPHIMURIUM | elegans | INFECTIOUS DISEASES | TRANSLATIONAL INHIBITION | VIRULENCE FACTORS
Journal Article
International Journal of Antimicrobial Agents, ISSN 0924-8579, 2016, Volume 48, Issue 6, pp. 583 - 591
Highlights • Colistin is a last-line drug against multidrug-resistant Gram-negative pathogens. • Chromosomal mutations and plasmid-borne mcr-1 remain the...
Infectious Disease | Lipid A modification | Colistin | Polymyxin B | mcr-1 | Antibiotic resistance | SPECTRUM-BETA-LACTAMASE | INFECTIOUS DISEASES | ESCHERICHIA-COLI | MICROBIOLOGY | ANTIMICROBIAL PEPTIDES | CARBAPENEM-RESISTANT | MCR-1-MEDIATED COLISTIN RESISTANCE | MEDIATED MCR-1 GENE | ACINETOBACTER-BAUMANNII | SALMONELLA-ENTERICA | PSEUDOMONAS-AERUGINOSA | KLEBSIELLA-PNEUMONIAE STRAINS | PHARMACOLOGY & PHARMACY | Gram-Negative Bacterial Infections - microbiology | Gram-Negative Bacteria - drug effects | Polymyxins - pharmacology | Animals | Plasmids | Humans | Anti-Bacterial Agents - pharmacology | Gram-Negative Bacteria - genetics | Drug Resistance, Bacterial - genetics | Gram-Negative Bacteria - isolation & purification | Drug resistance in microorganisms | Lipids | Bacterial infections | Gene mutations | Life Sciences | Human health and pathology | Infectious diseases
Infectious Disease | Lipid A modification | Colistin | Polymyxin B | mcr-1 | Antibiotic resistance | SPECTRUM-BETA-LACTAMASE | INFECTIOUS DISEASES | ESCHERICHIA-COLI | MICROBIOLOGY | ANTIMICROBIAL PEPTIDES | CARBAPENEM-RESISTANT | MCR-1-MEDIATED COLISTIN RESISTANCE | MEDIATED MCR-1 GENE | ACINETOBACTER-BAUMANNII | SALMONELLA-ENTERICA | PSEUDOMONAS-AERUGINOSA | KLEBSIELLA-PNEUMONIAE STRAINS | PHARMACOLOGY & PHARMACY | Gram-Negative Bacterial Infections - microbiology | Gram-Negative Bacteria - drug effects | Polymyxins - pharmacology | Animals | Plasmids | Humans | Anti-Bacterial Agents - pharmacology | Gram-Negative Bacteria - genetics | Drug Resistance, Bacterial - genetics | Gram-Negative Bacteria - isolation & purification | Drug resistance in microorganisms | Lipids | Bacterial infections | Gene mutations | Life Sciences | Human health and pathology | Infectious diseases
Journal Article
The Journal of antimicrobial chemotherapy, ISSN 0305-7453, 12/2015, Volume 70, Issue 12, pp. 3402 - 3404
ANTIBIOTIC-RESISTANCE | INFECTIOUS DISEASES | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | POULTRY | GENES | Escherichia coli - drug effects | Humans | Drug Resistance, Bacterial | Male | Multilocus Sequence Typing | Microbial Sensitivity Tests | Feces - microbiology | Colistin - pharmacology | Swine | Escherichia coli Infections - veterinary | Laos | Escherichia coli Infections - diagnosis | Escherichia coli Infections - microbiology | Genotype | Electrophoresis, Gel, Pulsed-Field | Swine Diseases - diagnosis | Swine Diseases - transmission | Animals | Escherichia coli - isolation & purification | Escherichia coli Infections - transmission | Adolescent | Anti-Bacterial Agents - pharmacology | Zoonoses - diagnosis | Zoonoses - microbiology | Escherichia coli - classification
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2016, Volume 16, Issue 2, pp. 147 - 147
Journal Article
International Journal of Antimicrobial Agents, ISSN 0924-8579, 2016, Volume 48, Issue 6, pp. 581 - 582
Infectious Disease | COLISTIN | INFECTIOUS DISEASES | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | Gram-Negative Bacterial Infections - microbiology | Anti-Bacterial Agents - therapeutic use | Gram-Negative Bacteria - drug effects | Polymyxins - pharmacology | Polymyxins - therapeutic use | Humans | Drug Resistance, Bacterial | Gram-Negative Bacterial Infections - drug therapy | Anti-Bacterial Agents - pharmacology | Drug resistance in microorganisms | Bacteria
Journal Article
International Journal of Antimicrobial Agents, ISSN 0924-8579, 2015, Volume 47, Issue 1, pp. 1 - 3
Abstract Colistin is currently regarded as one of the ‘last-resort’ antibiotics used for the treatment of critical infections caused by multidrug-resistant...
Infectious Disease | Cationic antimicrobial peptides | Veterinary | Enterobacteriaceae | INFECTIOUS DISEASES | ESCHERICHIA-COLI | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | KLEBSIELLA-PNEUMONIAE | MGRB | PIG | Gram-Negative Bacterial Infections - microbiology | Gram-Negative Bacteria - drug effects | Animals | Colistin - pharmacology | Prevalence | Humans | Drug Resistance, Bacterial | Gram-Negative Bacterial Infections - epidemiology | Anti-Bacterial Agents - pharmacology | Gram-Negative Bacterial Infections - veterinary | Gram-Negative Bacteria - isolation & purification | Gram-Negative Bacterial Infections - transmission | Colistin | Bacteria | Usage | Life Sciences | Human health and pathology | Infectious diseases
Infectious Disease | Cationic antimicrobial peptides | Veterinary | Enterobacteriaceae | INFECTIOUS DISEASES | ESCHERICHIA-COLI | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | KLEBSIELLA-PNEUMONIAE | MGRB | PIG | Gram-Negative Bacterial Infections - microbiology | Gram-Negative Bacteria - drug effects | Animals | Colistin - pharmacology | Prevalence | Humans | Drug Resistance, Bacterial | Gram-Negative Bacterial Infections - epidemiology | Anti-Bacterial Agents - pharmacology | Gram-Negative Bacterial Infections - veterinary | Gram-Negative Bacteria - isolation & purification | Gram-Negative Bacterial Infections - transmission | Colistin | Bacteria | Usage | Life Sciences | Human health and pathology | Infectious diseases
Journal Article
International Journal of Antimicrobial Agents, ISSN 0924-8579, 2014, Volume 44, Issue 6, pp. 500 - 507
Highlights • The human gut can harbour clonally unrelated colistin-resistant K. pneumoniae. • Mutation in mgrB is an emerging mechanism associated with...
Infectious Disease | Genome analysis | Colistin resistance | Two-component systems | Transposon | mgrB gene | Antibiotic resistance | Colistin resistance mgrB gene | INFECTIOUS DISEASES | BACTERIA | SUSCEPTIBILITY | CARBAPENEMASES | MICROBIOLOGY | COLONIZATION | ACINETOBACTER-BAUMANNII | EVOLUTION | BETA-LACTAMASE | PHARMACOLOGY & PHARMACY | ENTEROBACTERIACEAE | Amino Acid Sequence | France - epidemiology | Klebsiella pneumoniae - isolation & purification | Klebsiella Infections - drug therapy | Klebsiella pneumoniae - drug effects | Humans | Thailand - epidemiology | Bacterial Proteins - genetics | Drug Resistance, Bacterial | Molecular Sequence Data | Male | Klebsiella Infections - microbiology | Sequence Analysis, DNA | Laos - epidemiology | Feces - microbiology | Genome, Bacterial - genetics | Klebsiella Infections - epidemiology | Sequence Alignment | Colistin - pharmacology | Israel - epidemiology | Klebsiella pneumoniae - genetics | Nigeria - epidemiology | Anti-Bacterial Agents - pharmacology | Pneumonia | Antibacterial agents | Epidemiology | Bacterial pneumonia
Infectious Disease | Genome analysis | Colistin resistance | Two-component systems | Transposon | mgrB gene | Antibiotic resistance | Colistin resistance mgrB gene | INFECTIOUS DISEASES | BACTERIA | SUSCEPTIBILITY | CARBAPENEMASES | MICROBIOLOGY | COLONIZATION | ACINETOBACTER-BAUMANNII | EVOLUTION | BETA-LACTAMASE | PHARMACOLOGY & PHARMACY | ENTEROBACTERIACEAE | Amino Acid Sequence | France - epidemiology | Klebsiella pneumoniae - isolation & purification | Klebsiella Infections - drug therapy | Klebsiella pneumoniae - drug effects | Humans | Thailand - epidemiology | Bacterial Proteins - genetics | Drug Resistance, Bacterial | Molecular Sequence Data | Male | Klebsiella Infections - microbiology | Sequence Analysis, DNA | Laos - epidemiology | Feces - microbiology | Genome, Bacterial - genetics | Klebsiella Infections - epidemiology | Sequence Alignment | Colistin - pharmacology | Israel - epidemiology | Klebsiella pneumoniae - genetics | Nigeria - epidemiology | Anti-Bacterial Agents - pharmacology | Pneumonia | Antibacterial agents | Epidemiology | Bacterial pneumonia
Journal Article
Genome Biology and Evolution, ISSN 1759-6653, 2016, Volume 8, Issue 3, pp. 723 - 728
We performed a detailed whole-genome sequence analysis of Providencia rettgeri H1736, a multidrug-resistant clinical pathogen isolated in Israel in 2011. The...
Pathogenicity | Comparative genomics | Carbapenem biosynthesis | Virulence | Antibiotic resistance | carbapenem biosynthesis | BACTERIAL GENOMES | ISRAEL | comparative genomics | pathogenicity | EVOLUTIONARY BIOLOGY | virulence | METALLO-BETA-LACTAMASE | antibiotic resistance | BIOSYNTHESIS | GENES | GENETICS & HEREDITY | CONJUGATIVE ELEMENTS | REVEALS | Drug Resistance, Multiple - genetics | Enterobacteriaceae Infections - microbiology | Humans | Molecular Sequence Annotation | Gene Transfer, Horizontal | Phylogeny | Sequence Analysis, DNA | Providencia - pathogenicity | Anti-Bacterial Agents - therapeutic use | Genome, Bacterial - genetics | beta-Lactamases - genetics | Enterobacteriaceae Infections - genetics | Providencia - genetics | Evolution, Molecular | Life Sciences | Human health and pathology | Infectious diseases
Pathogenicity | Comparative genomics | Carbapenem biosynthesis | Virulence | Antibiotic resistance | carbapenem biosynthesis | BACTERIAL GENOMES | ISRAEL | comparative genomics | pathogenicity | EVOLUTIONARY BIOLOGY | virulence | METALLO-BETA-LACTAMASE | antibiotic resistance | BIOSYNTHESIS | GENES | GENETICS & HEREDITY | CONJUGATIVE ELEMENTS | REVEALS | Drug Resistance, Multiple - genetics | Enterobacteriaceae Infections - microbiology | Humans | Molecular Sequence Annotation | Gene Transfer, Horizontal | Phylogeny | Sequence Analysis, DNA | Providencia - pathogenicity | Anti-Bacterial Agents - therapeutic use | Genome, Bacterial - genetics | beta-Lactamases - genetics | Enterobacteriaceae Infections - genetics | Providencia - genetics | Evolution, Molecular | Life Sciences | Human health and pathology | Infectious diseases
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 10/2017, Volume 72, Issue 10, pp. 2715 - 2721
Background: Colistin is the last drug option for the treatment of MDR Gram-negative bacterial infections. Several types of resistance to colistin have been...
MARA | INFECTIOUS DISEASES | ROB | GENES | ANTIBIOTIC-RESISTANCE | HETERORESISTANCE | ACINETOBACTER | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | EXPRESSION | KLEBSIELLA-PNEUMONIAE | Enterobacter cloacae - drug effects | Enterobacter cloacae - genetics | Enterobacteriaceae Infections - microbiology | Humans | Bacterial Proteins - genetics | Transcription Factors - genetics | DNA Transposable Elements | Microbial Sensitivity Tests | Transcription Factors - metabolism | Carrier Proteins - genetics | Carrier Proteins - metabolism | Colistin - pharmacology | Bacterial Proteins - metabolism | Anti-Bacterial Agents - pharmacology | Enterobacter - drug effects | Enterobacter - isolation & purification | Enterobacter cloacae - isolation & purification | Mutagenesis, Insertional | Drug Resistance, Bacterial - genetics | Gene Expression Regulation, Bacterial | Enterobacter - genetics | Life Sciences | Human health and pathology
MARA | INFECTIOUS DISEASES | ROB | GENES | ANTIBIOTIC-RESISTANCE | HETERORESISTANCE | ACINETOBACTER | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | EXPRESSION | KLEBSIELLA-PNEUMONIAE | Enterobacter cloacae - drug effects | Enterobacter cloacae - genetics | Enterobacteriaceae Infections - microbiology | Humans | Bacterial Proteins - genetics | Transcription Factors - genetics | DNA Transposable Elements | Microbial Sensitivity Tests | Transcription Factors - metabolism | Carrier Proteins - genetics | Carrier Proteins - metabolism | Colistin - pharmacology | Bacterial Proteins - metabolism | Anti-Bacterial Agents - pharmacology | Enterobacter - drug effects | Enterobacter - isolation & purification | Enterobacter cloacae - isolation & purification | Mutagenesis, Insertional | Drug Resistance, Bacterial - genetics | Gene Expression Regulation, Bacterial | Enterobacter - genetics | Life Sciences | Human health and pathology
Journal Article
Microbial Drug Resistance, ISSN 1076-6294, 06/2015, Volume 21, Issue 3, pp. 279 - 285
Aim: The aim of this study was to investigate the prevalence and the mechanisms of carbapenem and colistin resistance in Acinetobacter baumannii clinical...
Epidemiology | IN-VIVO EMERGENCE | INACTIVATION | INFECTIOUS DISEASES | OUTBREAKS | MECHANISM | ENCODING GENES | PMRCAB OPERON | PHOSPHOETHANOLAMINE MODIFICATION | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | KLEBSIELLA-PNEUMONIAE | Algeria - epidemiology | Humans | Molecular Sequence Data | Male | Phylogeny | Multilocus Sequence Typing | Microbial Sensitivity Tests | Colistin - pharmacology | beta-Lactamases - genetics | Base Sequence | Edetic Acid - pharmacology | Acinetobacter baumannii - isolation & purification | Female | Clone Cells | beta-Lactamases - metabolism | Acinetobacter Infections - microbiology | Cross Infection - epidemiology | Acinetobacter Infections - drug therapy | Bacterial Proteins - genetics | Transcription Factors - genetics | Plasmids - metabolism | Sequence Analysis, DNA | Cross Infection - drug therapy | Imipenem - pharmacology | Acinetobacter baumannii - classification | Transcription Factors - metabolism | Sequence Alignment | Acinetobacter Infections - epidemiology | Cross Infection - microbiology | Plasmids - chemistry | Bacterial Proteins - metabolism | Anti-Bacterial Agents - pharmacology | Mutation | Acinetobacter baumannii - genetics | Drug Resistance, Multiple, Bacterial - genetics | Gene Expression Regulation, Bacterial | Genotype & phenotype | Bacteria | Nosocomial infections | Antibiotics | Drug resistance
Epidemiology | IN-VIVO EMERGENCE | INACTIVATION | INFECTIOUS DISEASES | OUTBREAKS | MECHANISM | ENCODING GENES | PMRCAB OPERON | PHOSPHOETHANOLAMINE MODIFICATION | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | KLEBSIELLA-PNEUMONIAE | Algeria - epidemiology | Humans | Molecular Sequence Data | Male | Phylogeny | Multilocus Sequence Typing | Microbial Sensitivity Tests | Colistin - pharmacology | beta-Lactamases - genetics | Base Sequence | Edetic Acid - pharmacology | Acinetobacter baumannii - isolation & purification | Female | Clone Cells | beta-Lactamases - metabolism | Acinetobacter Infections - microbiology | Cross Infection - epidemiology | Acinetobacter Infections - drug therapy | Bacterial Proteins - genetics | Transcription Factors - genetics | Plasmids - metabolism | Sequence Analysis, DNA | Cross Infection - drug therapy | Imipenem - pharmacology | Acinetobacter baumannii - classification | Transcription Factors - metabolism | Sequence Alignment | Acinetobacter Infections - epidemiology | Cross Infection - microbiology | Plasmids - chemistry | Bacterial Proteins - metabolism | Anti-Bacterial Agents - pharmacology | Mutation | Acinetobacter baumannii - genetics | Drug Resistance, Multiple, Bacterial - genetics | Gene Expression Regulation, Bacterial | Genotype & phenotype | Bacteria | Nosocomial infections | Antibiotics | Drug resistance
Journal Article
International Journal of Antimicrobial Agents, ISSN 0924-8579, 2015, Volume 47, Issue 1, pp. 4 - 5
Infectious Disease | INACTIVATION | INFECTIOUS DISEASES | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | EMERGENCE | KLEBSIELLA-PNEUMONIAE | MGRB | Enterobacteriaceae Infections - immunology | Swine Diseases - drug therapy | Animals | Polymyxins - therapeutic use | Humans | Plasmids - immunology | Enterobacteriaceae - drug effects | Colistin - therapeutic use | Enterobacteriaceae Infections - drug therapy | Antibacterial agents | Life Sciences | Human health and pathology | Infectious diseases
Journal Article
International Journal of Antimicrobial Agents, ISSN 0924-8579, 2015, Volume 46, Issue 3, pp. 354 - 355
Infectious Disease | INFECTIOUS DISEASES | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | Gene Expression | Colistin - pharmacology | Klebsiella oxytoca - genetics | Humans | Drug Resistance, Bacterial | Male | Anti-Bacterial Agents - pharmacology | Membrane Proteins - metabolism | Klebsiella oxytoca - drug effects | Antibacterial agents
Journal Article
Microbial Drug Resistance, ISSN 1076-6294, 08/2015, Volume 21, Issue 4, pp. 47 - 476
Serratia marcescens is one of the most important pathogens responsible for nosocomial infections worldwide. Here, we have investigated the molecular support of...
Epidemiology | SEQUENCE-ANALYSIS | INFECTIOUS DISEASES | ESCHERICHIA-COLI | ANTIBIOTIC-RESISTANCE | MICROBIOLOGY | TOF MASS-SPECTROMETRY | ACINETOBACTER-BAUMANNII | INTENSIVE-CARE-UNIT | MOLECULAR EPIDEMIOLOGY | PHARMACOLOGY & PHARMACY | ENTEROBACTER-CLOACAE | RIBOSOMAL-RNA METHYLASE | KLEBSIELLA-PNEUMONIAE | Conjugation, Genetic | Serratia marcescens - drug effects | Genes, Bacterial - genetics | Algeria - epidemiology | Humans | Serratia Infections - microbiology | Microbial Sensitivity Tests | Serratia Infections - epidemiology | Serratia marcescens - genetics | beta-Lactamases - genetics | Disease Outbreaks | Plasmids - genetics | RNA, Ribosomal, 16S - genetics | Serratia marcescens - enzymology | Anti-Bacterial Agents - pharmacology | Aminoglycosides - pharmacology | Drug Resistance, Bacterial - genetics | Genetics | Gram-negative bacteria | Antibiotics | Drug resistance
Epidemiology | SEQUENCE-ANALYSIS | INFECTIOUS DISEASES | ESCHERICHIA-COLI | ANTIBIOTIC-RESISTANCE | MICROBIOLOGY | TOF MASS-SPECTROMETRY | ACINETOBACTER-BAUMANNII | INTENSIVE-CARE-UNIT | MOLECULAR EPIDEMIOLOGY | PHARMACOLOGY & PHARMACY | ENTEROBACTER-CLOACAE | RIBOSOMAL-RNA METHYLASE | KLEBSIELLA-PNEUMONIAE | Conjugation, Genetic | Serratia marcescens - drug effects | Genes, Bacterial - genetics | Algeria - epidemiology | Humans | Serratia Infections - microbiology | Microbial Sensitivity Tests | Serratia Infections - epidemiology | Serratia marcescens - genetics | beta-Lactamases - genetics | Disease Outbreaks | Plasmids - genetics | RNA, Ribosomal, 16S - genetics | Serratia marcescens - enzymology | Anti-Bacterial Agents - pharmacology | Aminoglycosides - pharmacology | Drug Resistance, Bacterial - genetics | Genetics | Gram-negative bacteria | Antibiotics | Drug resistance
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 01/2015, Volume 59, Issue 1, pp. 745 - 746
SPECTRUM BETA-LACTAMASE | RESISTANCE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | KLEBSIELLA-PNEUMONIAE | Escherichia coli Infections - drug therapy | Genes, Bacterial - genetics | Escherichia coli Infections - microbiology | Molecular Sequence Data | Chickens - microbiology | beta-Lactamases - biosynthesis | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Escherichia coli Infections - epidemiology | Lebanon - epidemiology | Animals | beta-Lactamases - genetics | Escherichia coli - genetics | Escherichia coli - pathogenicity | Poultry Diseases - microbiology | Escherichia coli Infections - veterinary | Drug Resistance, Bacterial - genetics | Poultry Diseases - epidemiology | Letters to the Editor
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 11/2016, Volume 60, Issue 11, pp. 6994 - 6995
Journal Article